LB Pharmaceuticals Inc

LBRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 13, 2026
4 Oct 13, 2026
SCHEDULE 13G/A Oct 13, 2026
EFFECT Oct 5, 2026
POS AM Oct 1, 2026 POS AM
S-3ASR Oct 1, 2026 S-3ASR
3 Sep 24, 2026
424B3 Sep 15, 2026 424B3
8-K Sep 15, 2026 8-K
3 Sep 14, 2026
424B3 Sep 3, 2026 424B3
8-K Sep 3, 2026 8-K
SCHEDULE 13G/A Aug 14, 2026
424B3 Aug 11, 2026 424B3
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
4 Aug 3, 2026 4
SCHEDULE 13G/A Jul 29, 2026
424B3 Jul 29, 2026 424B3
8-K Jul 29, 2026 8-K
424B3 Jul 22, 2026 424B3
8-K Jul 22, 2026 8-K
SCHEDULE 13G Jul 16, 2026
424B3 Jun 10, 2026 424B3
8-K Jun 10, 2026 8-K
← Newer Page 1 of 6 · 141 filings Older →